| Michael J Bruwer, MD, PSYCH | |
|
470 S Ocotillo Ave, Benson, AZ 85602-6403 | |
| (520) 586-7737 | |
| (520) 586-7939 |
| Full Name | Michael J Bruwer |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 470 S Ocotillo Ave, Benson, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144394263 | NPI | - | NPPES |
| 258831 | Other | AZ | AHCCCS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | PSYCH 9113 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Bruwer, MD, PSYCH Po Box 42167, Tucson, AZ 85733-2167 Ph: (520) 326-9239 | Michael J Bruwer, MD, PSYCH 470 S Ocotillo Ave, Benson, AZ 85602-6403 Ph: (520) 586-7737 |
News Archive
Almost unnoticed in the wars over the federal budget has been a pitched battle over money for Planned Parenthood, which provides contraception, medical services and abortions at 800 clinics around the country. ... At stake is more than $75 million that Planned Parenthood receives to provide family planning assistance to low-income women, money that its opponents say only frees up funds for abortions (Eckholm, 2/17).
The success rate of in vitro fertilization (IVF) procedures still remains relatively low, at only around 30%. The high emotional, health and financial costs associated with having to undergo the procedure multiple times has driven the need to develop more efficient methods of assessing the development potential of embryos to ensure that only those with the highest potential are selected for IVF treatment.
A major study documenting outcomes for more than 400,000 surgical procedures performed in accredited office-based surgery facilities provides solid data confirming an overall safety record comparable to that of surgeries performed in hospital surgery facilities.
Researchers of the University of Oviedo have contributed to decipher the first epigenomes of chronic lymphocytic leukemia.
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that collaborators from the University of California, San Francisco (UCSF) presented results at the 2014 American Association for Cancer Research (AACR) conference, April 5-9, 2014 in San Diego, CA, highlighting the potential utility of imaging agents derived from Navidea's Manocept™ platform in identifying affected tissues and lymph nodes in patients with Kaposi Sarcoma (KS).
› Verified 9 days ago
Mrs. Gouni Lakoso Bouraima, PMHNP-BC Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 335 S Ocotillo Ave, Benson, AZ 85602 Phone: 520-586-4040 |